Literature DB >> 22938480

Mda-9/syntenin promotes human brain glioma migration through focal adhesion kinase (FAK)-JNK and FAK-AKT signaling.

Dong Zhong1, Jian-Hua Ran, Wen-Yuan Tang, Xiao-Dong Zhang, Yun Tan, Gui-Jie Chen, Xiao-Song Li, Yi Yan.   

Abstract

Invasion is usually recognized as the main reason for the high recurrence and death rates of glioma and restricts the efficacy of surgery and other therapies. Therefore, we aimed to investigate the mechanism involved in promotion effects of mda-9/syntenin on human glioma cell migration. The wound healing method was used to test the migration ability of human glioma cells CHG-5 and CHG-hS, stably overexpressing mda-9/syntenin. Western blotting was performed to determine the expression and phosphorylation of focal adhesion kinase (FAK) and JNK in CHG-5 and CHG-hS cells. The migration ability of CHG-hS cells was significantly higher than that of CHG-5 cells in fibronectin (FN)-coated culture plates. Phosphorylation of FAK on tyrosine 397, 576, and 925 sites was increased with time elapsed in CHG-hS cells. However, phosphorylated FAK on the tyrosine 861 site was not changed. Phosphorylated Src, JNK and Akt levels in CHG-hS cells were also significantly upregulated. Phosphorylation of JNK and Akt were abolished by the specific inhibitors SP600125 and LY294002, respectively. and the migration ability of CHG-hS cells was decreased, indicating that the JNK and PI3K/Akt pathways play important roles in regulating mda-9/syntenin-induced human brain glioma migration. Our results indicate Mda- 9/syntenin overexpression could activate FAK-JNK and FAK-Akt signaling and then enhance the migration capacity of human brain glioma cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22938480     DOI: 10.7314/apjcp.2012.13.6.2897

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  11 in total

1.  IL-6 increases SDCBP expression, cell proliferation, and cell invasion by activating JAK2/STAT3 in human glioma cells.

Authors:  Fang Cao; Qiang Zhang; Wei Chen; Chong Han; Yang He; Qishan Ran; Shengtao Yao
Journal:  Am J Transl Res       Date:  2017-10-15       Impact factor: 4.060

2.  MDA-9/syntenin is a key regulator of glioma pathogenesis.

Authors:  Timothy P Kegelman; Swadesh K Das; Bin Hu; Manny D Bacolod; Christine E Fuller; Mitchell E Menezes; Luni Emdad; Santanu Dasgupta; Albert S Baldwin; Jeffrey N Bruce; Paul Dent; Maurizio Pellecchia; Devanand Sarkar; Paul B Fisher
Journal:  Neuro Oncol       Date:  2013-12-04       Impact factor: 12.300

3.  SDCBP/MDA-9/syntenin phosphorylation by AURKA promotes esophageal squamous cell carcinoma progression through the EGFR-PI3K-Akt signaling pathway.

Authors:  Ruijuan Du; Chuntian Huang; Hanyong Chen; Kangdong Liu; Pu Xiang; Ning Yao; Lu Yang; Liting Zhou; Qiong Wu; Yaqiu Zheng; Mingxia Xin; Zigang Dong; Xiang Li
Journal:  Oncogene       Date:  2020-06-22       Impact factor: 9.867

4.  Syntenin is expressed in human gliomas and may correlate with tumor migration.

Authors:  Dong Zhong; Jianhua Ran; Xiaodong Zhang; Yun Tan; Guijie Chen; Wenyuan Tang; Xiaosong Li; Bing Wang
Journal:  Arch Med Sci       Date:  2015-12-04       Impact factor: 3.318

5.  Dissecting dysfunctional crosstalk pathways regulated by miRNAs during glioma progression.

Authors:  Yunpeng Zhang; Yanjun Xu; Feng Li; Xiang Li; Li Feng; Xinrui Shi; Lihua Wang; Xia Li
Journal:  Oncotarget       Date:  2016-05-03

Review 6.  MDA-9/Syntenin (SDCBP): Novel gene and therapeutic target for cancer metastasis.

Authors:  Swadesh K Das; Santanu Maji; Stephen L Wechman; Praveen Bhoopathi; Anjan K Pradhan; Sarmistha Talukdar; Devanand Sarkar; Joseph Landry; Chunqing Guo; Xiang-Yang Wang; Webster K Cavenee; Luni Emdad; Paul B Fisher
Journal:  Pharmacol Res       Date:  2020-02-13       Impact factor: 7.658

Review 7.  Examination of Epigenetic and other Molecular Factors Associated with mda-9/Syntenin Dysregulation in Cancer Through Integrated Analyses of Public Genomic Datasets.

Authors:  Manny D Bacolod; Swadesh K Das; Upneet K Sokhi; Steven Bradley; David A Fenstermacher; Maurizio Pellecchia; Luni Emdad; Devanand Sarkar; Paul B Fisher
Journal:  Adv Cancer Res       Date:  2015-05-23       Impact factor: 6.242

Review 8.  Targeting tumor invasion: the roles of MDA-9/Syntenin.

Authors:  Timothy P Kegelman; Swadesh K Das; Luni Emdad; Bin Hu; Mitchell E Menezes; Praveen Bhoopathi; Xiang-Yang Wang; Maurizio Pellecchia; Devanand Sarkar; Paul B Fisher
Journal:  Expert Opin Ther Targets       Date:  2014-09-15       Impact factor: 6.902

9.  Elevated expression of syntenin in breast cancer is correlated with lymph node metastasis and poor patient survival.

Authors:  Yu Yang; Qi Hong; Pengcheng Shi; Zhebin Liu; Jianmin Luo; Zhiming Shao
Journal:  Breast Cancer Res       Date:  2013-06-20       Impact factor: 6.466

10.  Effects of syndecan-1 on the expression of syntenin and the migration of U251 glioma cells.

Authors:  Jun Chen; Jun Tang; Wei Chen; Yang Gao; Yang He; Qiang Zhang; Qishan Ran; Fang Cao; Shengtao Yao
Journal:  Oncol Lett       Date:  2017-10-11       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.